These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 13540175)

  • 1. [Clinical experiences with BCM (degranol) beta-bis-chlorethylamino-D-mannitoldichlorhydrate].
    ECKHARDT A; SELLEI C; MOLNAR A; HARTAI F
    Krebsarzt; 1958 Feb; 13(2):73-5. PubMed ID: 13540175
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and experimental results with BCM (beta-bis-1, 6-chloroethylamino-D-mannitol dihydrochloride)].
    SELLEI K; NEMETH L; ECKHARDT S; KELLNER B
    Magy Tud; 1957; 8(1-2):119-21. PubMed ID: 13450596
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disappearance of symptoms of granuloma fungoides after mustard mannitol (BCM) therapy].
    BAKOS L; VENKEI T
    Orv Hetil; 1957 Apr; 98(17):442. PubMed ID: 13452498
    [No Abstract]   [Full Text] [Related]  

  • 4. [1, 6-Bis(beta-chlorethylamino)-1, 6-desoxy-D-mannit dichlorhydrate (BCM), a new nitrogen derivative].
    KELLNER B; NEMETH L
    Z Krebsforsch; 1956; 61(2):165-79. PubMed ID: 13353379
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pre- and post-operative dosage of degranol in operable cancer patients].
    RUBANYI P; SZEKELY J; NEMETH E
    Magy Seb; 1959 Mar; 12(1):65-8. PubMed ID: 13643065
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical observations with 1, 6-bis(beta-chloroethylamino)-1, 6-deoxy-D-mannitol dihydrochloride (BCM) in malignant diseases.
    SELLEI C; ECKHARDT S
    Ann N Y Acad Sci; 1958 Apr; 68(3):1164-80. PubMed ID: 13627769
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental and clinical experiences with degranol].
    BENKO S
    Orv Hetil; 1958 Jul; 99(27):914-7. PubMed ID: 13566811
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trials of mechlorethamine-N-oxide in therapy of tumors].
    SELLEI C; ECKHARDT A
    Munch Med Wochenschr; 1958 May; 100(19):784-6. PubMed ID: 13565952
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on a cytostatic mannitol derivative (BCM)].
    ECKHARDT S; HARTAI F; MOLNAR E; SELLEI C
    Orv Hetil; 1956 Sep; 97(36):999-1001. PubMed ID: 13388313
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental and clinical facts about degranol.
    BENKO S
    Ther Hung; 1958; 6(1):15-8. PubMed ID: 13625185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trials of a new nitrogen mustard, MX 101].
    IZARN P; POURQUIER H; GARY-BOBO J; PUJOL H; EMBERGER JM
    Montp Med; 1960 Nov; 58():178-83. PubMed ID: 13718407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the inhibiting effect of a new nitrogen mustard derivative, 1, 6-bis(beta-chloraethylamino)-1, 6-desoxy-D-mannitol dihydrochloride (BCM), on tumor growth].
    KELLNER B; NEMETH L
    Orv Hetil; 1956 Sep; 97(36):981-4. PubMed ID: 13388307
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
    ZULIK R
    Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105
    [No Abstract]   [Full Text] [Related]  

  • 14. [An experiment on increasing the effect of cytostatic drugs; increasing the active dosage of BCM through simultaneous use of a hibernation mixture].
    SELLEI C; HARTAI F; MOLNAR E; ECKHARDT S
    Medizinische; 1957 May; (19):722-3. PubMed ID: 13440433
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with the cytostatic agent mannitol-lost (Degranol)].
    PETERSEN W
    Med Klin; 1961 Aug; 56():1459-61. PubMed ID: 13734821
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathological and clinical effects of 1.6-bis(beta-chloraethylamino)-1.6-desoxy-D-mannite-dichlorhydrate/BCM.
    KELLNER B; NEMETH L; SELLEI C
    Acta Unio Int Contra Cancrum; 1957; 13(3):473-9. PubMed ID: 13469609
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with nitrogen mustards. V. Therapy of malignant tumors].
    CERNIK F; LUKL P; PROCHAZKA J; VIZDA J
    Cas Lek Cesk; 1952 Jan; 91(2):44-9. PubMed ID: 14390080
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytostatic drugs in the treatment of malignant tumors; clinical experiences with mitomen].
    APEL G; KLAGES K
    Medizinische; 1957 Mar; (9):314-8. PubMed ID: 13430178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with clinical use of some new chemotherapeutics in tumor therapy].
    PEREVODCHIKOVA NJ
    Dtsch Med Wochenschr; 1958 Jan; 83(1):21-3. PubMed ID: 13500993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on three years of clinical experience with nitrogen mustard].
    CUCINOTTA U
    G Ital Chemioter; 1954; 1(1):175-7. PubMed ID: 13191617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.